Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-12

FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for NURTEC ODT (rimegepant sulfate) from Pfizer Laboratories Div Pfizer Inc, related to the product's regulatory fil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

SUPPL AP for NURTEC ODT (RIMEGEPANT SULFATE)